These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29246961)

  • 1. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis.
    Alsaied T; Baskar S; Fares M; Alahdab F; Czosek RJ; Murad MH; Prokop LJ; Divanovic AA
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
    Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis.
    Hill GD; Kovach JR; Saudek DE; Singh AK; Wehrheim K; Frommelt MA
    Prenat Diagn; 2017 Nov; 37(11):1076-1083. PubMed ID: 28833310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols.
    Sridharan S; Sullivan I; Tomek V; Wolfenden J; Škovránek J; Yates R; Janoušek J; Dominguez TE; Marek J
    Heart Rhythm; 2016 Sep; 13(9):1913-9. PubMed ID: 27554948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia.
    Strizek B; Berg C; Gottschalk I; Herberg U; Geipel A; Gembruch U
    Heart Rhythm; 2016 Jun; 13(6):1283-8. PubMed ID: 26829115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
    Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
    Tunca Sahin G; Beattie RB; Uzun O
    Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial.
    Miyoshi T; Maeno Y; Sago H; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Shozu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Ikeda T; Yamamoto H; Hamasaki T;
    BMJ Open; 2017 Aug; 7(8):e016597. PubMed ID: 28851790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
    J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
    O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin, flecainide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate.
    Schmolling J; Renke K; Richter O; Pfeiffer K; Schlebusch H; Höller T
    Ther Drug Monit; 2000 Oct; 22(5):582-8. PubMed ID: 11034264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal arrhythmia: prenatal diagnosis and perinatal management.
    Maeno Y; Hirose A; Kanbe T; Hori D
    J Obstet Gynaecol Res; 2009 Aug; 35(4):623-9. PubMed ID: 19751319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
    Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M
    J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Fetal Supraventricular Tachycardia: Case Series from a Tertiary Perinatal Cardiac Center.
    Broom E; Thomas JT; Petersen S; Gooi A; Ward C; Gardener G; Kostner K; Lee-Tannock A; Kumar S
    Fetal Diagn Ther; 2021; 48(11-12):794-800. PubMed ID: 34753148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide as first-line treatment for fetal supraventricular tachycardia.
    Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.
    Krapp M; Kohl T; Simpson JM; Sharland GK; Katalinic A; Gembruch U
    Heart; 2003 Aug; 89(8):913-7. PubMed ID: 12860871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
    Parilla BV; Strasburger JF; Socol ML
    Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
    Agarwal A; Saha SC; Kaur A; Naganur S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.